|Videos|October 20, 2017

Older Aged Population Disproportionately Affected by Influenza

William Schaffner, MD, discusses how the adults aged 65 and older are disproportionately affected by influenza.

William Schaffner, MD, medical director for the National Foundation for Infectious Diseases (NFID) and infectious disease physician at Vanderbilt, discusses how the adults aged 65 and older are disproportionately affected by influenza, accounting for the majority of hospitalizations each year. Dr. Schaffner stresses that although two-thirds of this population is vaccinated each year, one-third remains unvaccinated, which leaves a staggering 15 million individuals unprotected against influenza; this underscores the need to vaccinate this population "much more comprehensively."


Related to this article

REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
GSK's mRNA Influenza Vaccine Moves to Phase 3 Trial
GSK will advance its investigational mRNA seasonal flu vaccine candidate, which targets both hemagglutinin and neuraminidase, into a phase 3 trial in September 2026 after the shot outperformed licensed flu vaccines in a phase 2 study.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.